Literature DB >> 13783268

The clinical features of hypercalcemia associated with malignant disease.

O H WARWICK, E R YENDT, J S OLIN.   

Abstract

Entities:  

Keywords:  CALCIUM/blood; NEOPLASMS/blood

Mesh：

Substances：

Year:  1961        PMID： 13783268      PMCID： PMC1848341     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Renal failure during acute hypercalcaemia in patients with metastasized mammary carcinoma.

Authors:  J GERBRANDY; H B HELLENDOORN
Journal:  Clin Chim Acta       Date:  1958-09       Impact factor: 3.786

2.  Abnormalities in calcium metabolism in malignancy; effects of hormone therapy.

Authors:  W H BAKER
Journal:  Am J Med       Date:  1956-11       Impact factor: 4.965

3.  Hypercalcemia in neoplastic disease.

Authors:  W P L MYERS
Journal:  Cancer       Date:  1956 Nov-Dec       Impact factor: 6.860

4.  Biochemical alterations during steroid hormone therapy of advanced breast cancer.

Authors:  B J KENNEDY; I T NATHANSON; D M TIBBETTS; J C AUB
Journal:  Am J Med       Date:  1955-09       Impact factor: 4.965

5.  Hypercalcemia secondary to bone metastases from carcinoma of the breast. I. Relationship between serum calcium and alkaline phosphatase values.

Authors:  S I GRIBOFF; J B HERRMANN; A SMELIN; J MOSS
Journal:  J Clin Endocrinol Metab       Date:  1954-04       Impact factor: 5.958

6.  Evaluation of endocrine therapy for advanced breast cancer.

Authors:  O H PEARSON; C D WEST; V P HOLLANDER; N E TREVES
Journal:  J Am Med Assoc       Date:  1954-01-16

7.  THE FUNCTIONAL PATHOLOGY OF HYPER-PARATHYROIDISM.

Authors:  H A Bulger; H H Dixon; D P Barr; O Schregardus
Journal:  J Clin Invest       Date:  1930-08       Impact factor: 14.808

8.  Mineral and protein metabolism in osteolytic metastases.

Authors:  D LASZLO; C A SCHULMAN; J BELLIN; E D GOTTESMAN; A SCHILLING
Journal:  J Am Med Assoc       Date:  1952-03-22
  8 in total
  11 in total

Review 1.  HYPERCALCAEMIA AND CANCER.

Authors:  L WATSON
Journal:  Postgrad Med J       Date:  1963-11       Impact factor: 2.401

2.  The extrarenal manifestations of hypernephroma.

Authors:  D A GORDON
Journal:  Can Med Assoc J       Date:  1963-01-12       Impact factor: 8.262

3.  Chemotherapy of malignant disease: a review of theory and practice.

Authors:  G D HART
Journal:  Can Med Assoc J       Date:  1962-03-31       Impact factor: 8.262

Review 4.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

5.  Tumor hypercalcemia.

Authors:  B S Roof
Journal:  Calif Med       Date:  1973-01

6.  O. Harold Warwick: Canada's first medical oncologist.

Authors:  D H Cowan
Journal:  Curr Oncol       Date:  2011-06       Impact factor: 3.677

Review 7.  Medical management of hypercalcaemia.

Authors:  S H Ralston
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

8.  Hormonal treatment of hypercalcemia caused by bone metastases.

Authors:  W Muirhead
Journal:  Can Med Assoc J       Date:  1967-09-09       Impact factor: 8.262

9.  Occult manifestations of cancer.

Authors:  R D HENDERSON
Journal:  Can Med Assoc J       Date:  1963-01-05       Impact factor: 8.262

10.  CARCINOMA OF LUNG WITH ADRENAL HYPERFUNCTION AND HYPERCALCEMIA TREATED BY PARATHYROIDECTOMY.

Authors:  M H GAULT; T D KINSELLA
Journal:  Can Med Assoc J       Date:  1965-02-13       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.